SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Fuse Medical, Inc. – ‘10-K’ for 12/31/20 – ‘EX-21.1’

On:  Tuesday, 3/30/21, at 6:39pm ET   ·   As of:  3/31/21   ·   For:  12/31/20   ·   Accession #:  1564590-21-16781   ·   File #:  0-10093

Previous ‘10-K’:  ‘10-K’ on 3/30/20 for 12/31/19   ·   Next:  ‘10-K’ on 3/31/22 for 12/31/21   ·   Latest:  ‘10-K’ on 4/14/23 for 12/31/22   ·   23 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/21  Fuse Medical, Inc.                10-K       12/31/20   72:7.1M                                   ActiveDisclosure/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    751K 
 2: EX-10.21    Material Contract                                   HTML     28K 
 3: EX-21.1     Subsidiaries List                                   HTML     20K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML     21K 
 5: EX-23.2     Consent of Expert or Counsel                        HTML     21K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
15: R1          Document and Entity Information                     HTML     82K 
16: R2          Consolidated Balance Sheets                         HTML    106K 
17: R3          Consolidated Balance Sheets (Parenthetical)         HTML     44K 
18: R4          Consolidated Statements of Operations               HTML     91K 
19: R5          Consolidated Statement of Changes in Stockholders'  HTML     46K 
                Equity                                                           
20: R6          Consolidated Statements of Cash Flows               HTML     99K 
21: R7          Nature of Operations                                HTML     34K 
22: R8          Significant Accounting Policies                     HTML     85K 
23: R9          Property and Equipment                              HTML     45K 
24: R10         Goodwill and Intangible Assets                      HTML     78K 
25: R11         Senior Secured Revolving Credit Facility            HTML     30K 
26: R12         Notes Payable - Related Parties                     HTML     24K 
27: R13         Paycheck Protection Program Loan                    HTML     24K 
28: R14         Economic Injury Disaster Loan                       HTML     24K 
29: R15         Commitments and Contingencies                       HTML     39K 
30: R16         Stockholders' Equity                                HTML    132K 
31: R17         Income Taxes                                        HTML    148K 
32: R18         Concentrations                                      HTML     49K 
33: R19         Related Party Transactions                          HTML     46K 
34: R20         Subsequent Events                                   HTML     25K 
35: R21         Significant Accounting Policies (Policies)          HTML    136K 
36: R22         Significant Accounting Policies (Tables)            HTML     49K 
37: R23         Property and Equipment (Tables)                     HTML     44K 
38: R24         Goodwill and Intangible Assets (Tables)             HTML     78K 
39: R25         Commitments and Contingencies (Tables)              HTML     36K 
40: R26         Stockholders' Equity (Tables)                       HTML    131K 
41: R27         Income Taxes (Tables)                               HTML    148K 
42: R28         Concentrations (Tables)                             HTML     53K 
43: R29         Nature of Operations (Details Narrative)            HTML     75K 
44: R30         Significant Accounting Policies (Details            HTML    102K 
                Narrative)                                                       
45: R31         Significant Accounting Policies - Estimated Useful  HTML     31K 
                Lives of Assets (Details)                                        
46: R32         Significant Accounting Policies - Schedule of       HTML     31K 
                Revenue Differentiation (Details)                                
47: R33         Property and Equipment - Summary of Property and    HTML     33K 
                Equipment (Details)                                              
48: R34         Property and Equipment (Details Narrative)          HTML     25K 
49: R35         Goodwill and Intangible Assets - Schedule of        HTML     47K 
                Goodwill and Other Intangible Assets (Details)                   
50: R36         Goodwill and Intangible Assets - (Details           HTML     26K 
                Narrative)                                                       
51: R37         Goodwill and Intangible Assets - Schedule of        HTML     37K 
                Future Amortization Expense Related to Finite-Live               
                Intangible Assets (Details)                                      
52: R38         Senior Secured Revolving Credit Facility (Details   HTML    137K 
                Narrative)                                                       
53: R39         Notes Payable - Related Parties (Details            HTML     59K 
                Narrative)                                                       
54: R40         Paycheck Protection Program Loan (Details           HTML     39K 
                Narrative)                                                       
55: R41         Economic Injury Disaster Loan (Details Narrative)   HTML     51K 
56: R42         Commitments and Contingencies (Details Narrative)   HTML     37K 
57: R43         Commitments and Contingencies - Summary of          HTML     31K 
                Operating Leases (Details)                                       
58: R44         Stockholders' Equity - Summary of Compensation      HTML     38K 
                Expense for Stock Options Granted to Board                       
                Members, Employees And Marketing Representatives                 
                (Details)                                                        
59: R45         Stockholders' Equity (Details Narrative)            HTML     33K 
60: R46         Stockholders' Equity - Summary of Stock Option      HTML     52K 
                Activity (Details)                                               
61: R47         Stockholders' Equity - Summary of Restricted Stock  HTML     42K 
                Awards Activity (Details)                                        
62: R48         Income Taxes - Components of Income Tax Expense     HTML     42K 
                (Benefit) (Details)                                              
63: R49         Income Taxes - Significant Components of Deferred   HTML     53K 
                Income Tax Assets and Liabilities (Details)                      
64: R50         Income Taxes (Details Narrative)                    HTML     36K 
65: R51         Income Taxes - Reconciliation of Income Tax         HTML     35K 
                Computed at U.S. Statutory Rate to Effective                     
                Income Tax Rate (Details)                                        
66: R52         Concentrations - Significant Customers with         HTML     29K 
                Individual Percentage of Total Revenues Equaling                 
                Ten Percent (10%) or Greater (Details)                           
67: R53         Concentrations - Significant Customers with         HTML     29K 
                Concentration of Accounts Receivable Representing                
                Ten Percent (10%) or Greater of Accounts                         
                Receivable (Parenthetical) (Details)                             
68: R54         Concentrations - Significant Customers with         HTML     31K 
                Concentration of Accounts Receivable Representing                
                Ten Percent (10%) or Greater of Accounts                         
                Receivable (Details)                                             
69: R55         Related Party Transactions (Details Narrative)      HTML     87K 
71: XML         IDEA XML File -- Filing Summary                      XML    127K 
70: EXCEL       IDEA Workbook of Financial Reports                  XLSX     87K 
 9: EX-101.INS  XBRL Instance -- fzmd-20201231                       XML   1.65M 
11: EX-101.CAL  XBRL Calculations -- fzmd-20201231_cal               XML    160K 
12: EX-101.DEF  XBRL Definitions -- fzmd-20201231_def                XML    543K 
13: EX-101.LAB  XBRL Labels -- fzmd-20201231_lab                     XML   1.26M 
14: EX-101.PRE  XBRL Presentations -- fzmd-20201231_pre              XML    917K 
10: EX-101.SCH  XBRL Schema -- fzmd-20201231                         XSD    181K 
72: ZIP         XBRL Zipped Folder -- 0001564590-21-016781-xbrl      Zip    141K 


‘EX-21.1’   —   Subsidiaries List


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

Exhibit 21.1

 

Fuse Medical, Inc.

(A Delaware Corporation)

 

List of Significant Subsidiaries

(As of December 31, 2019)

 

CPM Medical Consultants, LLC

Palm Springs Partners, LLC D/B/A Maxim Surgical

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:3/31/2110-Q
Filed on:3/30/21
For Period end:12/31/20
12/31/1910-K
 List all Filings 


23 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/16/20  Fuse Medical, Inc.                10-Q        9/30/20   64:5.9M                                   ActiveDisclosure/FA
 8/07/20  Fuse Medical, Inc.                10-Q        6/30/20   65:6.1M                                   ActiveDisclosure/FA
 5/22/20  Fuse Medical, Inc.                10-Q        3/31/20   64:6.3M                                   ActiveDisclosure/FA
 3/30/20  Fuse Medical, Inc.                10-K       12/31/19   75:7.3M                                   ActiveDisclosure/FA
12/20/19  Fuse Medical, Inc.                8-K:1,9    12/18/19    2:312K                                   ActiveDisclosure/FA
 5/13/19  Fuse Medical, Inc.                8-K:1,2,9   5/09/19    2:66K                                    Donnelley … Solutions/FA
 3/21/19  Fuse Medical, Inc.                10-K       12/31/18  120:42M                                    ActiveDisclosure/FA
 3/21/19  Fuse Medical, Inc.                8-K:5,9     3/20/19    2:213K                                   Donnelley … Solutions/FA
12/18/18  Fuse Medical, Inc.                8-K:1,5,9  12/13/18    4:266K                                   Donnelley … Solutions/FA
11/21/18  Fuse Medical, Inc.                8-K:1,2,7,911/19/18    4:124K                                   Donnelley … Solutions/FA
 7/05/18  Fuse Medical, Inc.                8-K:5,9     6/28/18    2:24K                                    Donnelley … Solutions/FA
 4/06/18  Fuse Medical, Inc.                10-K       12/31/17   80:9M                                     ActiveDisclosure/FA
 2/23/18  Fuse Medical, Inc.                8-K:7,9     2/15/18    2:21K                                    Donnelley … Solutions/FA
 1/11/18  Fuse Medical, Inc.                8-K:2,4,8,9 1/05/18    4:642K                                   ActiveDisclosure/FA
12/20/17  Fuse Medical, Inc.                8-K:1,5,7,912/14/17    4:4.7M                                   ActiveDisclosure/FA
11/06/17  Fuse Medical, Inc.                8-K/A:5,9   9/21/17    3:45K                                    ActiveDisclosure/FA
 4/06/17  Fuse Medical, Inc.                8-K:1,5,9   3/31/17    4:277K                                   ActiveDisclosure/FA
 3/20/17  Fuse Medical, Inc.                10-K       12/31/16   64:5.8M                                   ActiveDisclosure/FA
12/23/16  Fuse Medical, Inc.                8-K:1,3,5,712/19/16    8:714K                                   Donnelley … Solutions/FA
12/04/15  Fuse Medical, Inc.                DEF 14C    12/04/15    1:48K                                    Discount Edgar/FA
 9/15/14  Fuse Medical, Inc.                8-K:1,5,9   9/11/14    3:152K                                   Discount Edgar/FA
 8/29/14  Fuse Medical, Inc.                8-K/A¶:1,2, 5/28/14   27:4.2M                                   Discount Edgar/FA
 5/29/14  Fuse Medical, Inc.                8-K:1,2,3,5 5/28/14   10:2.9M                                   Discount Edgar/FA
Top
Filing Submission 0001564590-21-016781   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 5, 1:47:18.3am ET